Solid phase anti-C3 assay for detection of immune complexes
AssigneeScripps Clinic and Research Foundation
InventorsArgyrios N. Theofilopoulos, Frank J. Dixon
Life of this patent
Estimating the term…
Abstract
A solid phase assay which specifically detects C-fixing ICs by reacting ICs or aggregated gammaglobulin in normal serum with matrix-bound F(ab')2 anti-C3 and measuring the amount of Ig by radioimmunoassay or enzyme-linking techniques, and means for carrying out the assay are disclosed.
Claims5
An assay method for immune complexes comprising the steps of binding F(ab')2 anti-C3 to a solid substrate, reacting the fluid suspected of containing immune complexes with the bound F(ab')2 anti-C3, and determining the amount of bound immune complexes on said substrate.
In the assay for immune complexes wherein the immune complexes are bound with a binding reagent having excess binding sites and the quantity of bound immune complexes is determined by detecting the quantity of sites not bound by immune complexes, the improvement wherein the binding reagent is F(ab')2 anti-C3 bound to a solid matrix.
In the assay for immune complexes wherein binding means are provided for binding such immune complexes, reacting said binding means with said immune complexes, reacting sites on said binding means which are not bound to immune complexes with a detectable reagent means and quantitatively measuring the amount of detectable reagent means, the improvement comprising a solid substrate and F(ab')2 anti-C3 reagent bound on the surface of said substrate as the binding means.
An assay means for use in connection with samples suspected of containing immune complexes and reagents capable of being quantitatively measured when bound to such assay means, said assay means comprising a solid substrate and a layer of F(ab')2 anti-C3 reagent bound on the surface of said solid substrate.
A method for determining immune complexes comprising reacting said immune complexes with binding means comprising a solid substrate coated with F(ab')2 anti-C3 and quantitatively determining the amount of immune complexes bound on said substrate coated with F(ab')2 anti-C3.
Dependencies are inferred from the claim text.